These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20687841)

  • 1. Remission of severe CD8(+) cytotoxic T cell skin infiltrative disease in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Sbidian E; Battistella M; Rivet J; Flageul B; Molina JM; Joly P; Caumes E; Gorochov G; Cayuela JM; Rabian C; Dupin N; Lebbé C; Janin A; Janier M; Oksenhendler E; Bachelez H
    Clin Infect Dis; 2010 Sep; 51(6):741-8. PubMed ID: 20687841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection.
    Lascar RM; Lopes AR; Gilson RJ; Dunn C; Johnstone R; Copas A; Reignat S; Webster G; Bertoletti A; Maini MK
    J Infect Dis; 2005 Apr; 191(7):1169-79. PubMed ID: 15747254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.
    Kou ZC; Puhr JS; Wu SS; Goodenow MM; Sleasman JW
    J Infect Dis; 2003 Feb; 187(3):385-97. PubMed ID: 12552422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
    Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia.
    Wilkinson J; Zaunders JJ; Carr A; Cooper DA
    J Infect Dis; 1999 Jul; 180(1):68-75. PubMed ID: 10353863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
    Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antiretroviral therapy on programmed death-1 (CD279) expression on T cells in lymph nodes of human immunodeficiency virus-infected individuals.
    Ehrhard S; Wernli M; Dürmüller U; Battegay M; Gudat F; Erb P
    Hum Pathol; 2009 Oct; 40(10):1427-33. PubMed ID: 19439344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8 T-cell response to antiretroviral therapy.
    Stricker RB; Goldberg B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):176-7. PubMed ID: 9241121
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells.
    Lilleri D; Chiesa A; Fornara C; Maserati R; Lozza L; Comolli G; Gerna G
    Clin Microbiol Infect; 2007 Jan; 13(1):19-24. PubMed ID: 17184283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.
    Wellons MF; Ottinger JS; Weinhold KJ; Gryszowka V; Sanders LL; Edwards LJ; Gooding ME; Thomasch JR; Bartlett JA
    J Infect Dis; 2001 May; 183(10):1522-5. PubMed ID: 11319689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
    Seth A; Markee J; Hoering A; Sevin A; Sabath DE; Schmitz JE; Kuroda MJ; Lifton MA; Hirsch MS; Collier AC; Letvin NL; McElrath MJ
    J Infect Dis; 2001 Mar; 183(5):722-9. PubMed ID: 11181148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy.
    Resino S; Bellón JM; Gurbindo MD; Muñoz-Fernández MA
    Clin Infect Dis; 2004 Feb; 38(3):412-7. PubMed ID: 14727214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral panuveitis in HIV-1-infected patients with CD8 lymphocytosis.
    De Silva DJ; Obi AA; Mitchell SM
    Ocul Immunol Inflamm; 2005; 13(4):311-6. PubMed ID: 16159723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children.
    Spiegel HM; Chandwani R; Sheehy ME; Dobroszycki J; Fennelly G; Wiznia A; Radding J; Rigaud M; Pollack H; Borkowsky W; Rosenberg M; Nixon DF
    J Infect Dis; 2000 Jul; 182(1):88-95. PubMed ID: 10882585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
    Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
    Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.